Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Non-Current Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Non-Current Assets for 5 consecutive years, with $10.8 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 22.02% to $10.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.2 million through Dec 2025, down 39.75% year-over-year, with the annual reading at $10.8 million for FY2025, 22.02% down from the prior year.
  • Non-Current Assets for Q4 2025 was $10.8 million at Werewolf Therapeutics, down from $11.5 million in the prior quarter.
  • The five-year high for Non-Current Assets was $38.5 million in Q1 2023, with the low at $4.0 million in Q3 2021.
  • Average Non-Current Assets over 5 years is $19.4 million, with a median of $16.5 million recorded in 2021.
  • The sharpest move saw Non-Current Assets soared 424.73% in 2022, then crashed 63.82% in 2025.
  • Over 5 years, Non-Current Assets stood at $18.2 million in 2021, then rose by 10.25% to $20.0 million in 2022, then skyrocketed by 81.91% to $36.5 million in 2023, then tumbled by 61.98% to $13.9 million in 2024, then decreased by 22.02% to $10.8 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $10.8 million, $11.5 million, and $12.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.